Literature DB >> 17289675

Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.

Brian D Thompson1, Yongzhu Jin, Kevin H Wu, Richard A Colvin, Andrew D Luster, Lutz Birnbaumer, Mei X Wu.   

Abstract

G protein-coupled receptors (GPCRs) convey extracellular stimulation into dynamic intracellular action, leading to the regulation of cell migration and differentiation. T lymphocytes express G alpha(i2) and G alpha(i3), two members of the G alpha(i/o) protein family, but whether these two G alpha(i) proteins have distinguishable roles guiding T cell migration remains largely unknown because of a lack of member-specific inhibitors. This study details distinct G alpha(i2) and G alpha(i3) effects on chemokine receptor CXCR3-mediated signaling. Our data showed that G alpha(i2) was indispensable for T cell responses to three CXCR3 ligands, CXCL9, CXCL10, and CXCL11, as the lack of G alpha(i2) abolished CXCR3-stimulated migration and guanosine 5'-3-O-(thio)triphosphate (GTPgammaS) incorporation. In sharp contrast, T cells isolated from G alpha(i3) knock-out mice displayed a significant increase in both GTPgammaS incorporation and migration as compared with wild type T cells when stimulated with CXCR3 agonists. The increased GTPgammaS incorporation was blocked by G alpha(i3) protein in a dose-dependent manner. G alpha(i3)-mediated blockade of G alpha(i2) activation did not result from G alpha(i3) activation, but instead resulted from competition or steric hindrance of G alpha(i2) interaction with the CXCR3 receptor via the N terminus of the second intracellular loop. A mutation in this domain abrogated not only G alpha(i2) activation induced by a CXCR3 agonist but also the interaction of G alpha(i3) to the CXCR3 receptor. These findings reveal for the first time an interplay of G alpha(i) proteins in transmitting G protein-coupled receptor signals. This interplay has heretofore been masked by the use of pertussis toxin, a broad inhibitor of the G alpha(i/o) protein family.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289675      PMCID: PMC2366813          DOI: 10.1074/jbc.M610931200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  How activated receptors couple to G proteins.

Authors:  H E Hamm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection.

Authors:  I A Khan; J A MacLean; F S Lee; L Casciotti; E DeHaan; J D Schwartzman; A D Luster
Journal:  Immunity       Date:  2000-05       Impact factor: 31.745

3.  Mouse gene knockout and knockin strategies in application to alpha subunits of Gi/Go family of G proteins.

Authors:  Meisheng Jiang; Karsten Spicher; Guylain Boulay; Angeles Martín-Requero; Catherine A Dye; Uwe Rudolph; Lutz Birnbaumer
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

4.  Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism.

Authors:  Zheng Zhang; Levent Kaptanoglu; Wael Haddad; David Ivancic; Ziad Alnadjim; Stephen Hurst; Darren Tishler; Andrew D Luster; Terrence A Barrett; Jonathan Fryer
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

5.  Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states.

Authors:  M A Cox; C H Jenh; W Gonsiorek; J Fine; S K Narula; P J Zavodny; R W Hipkin
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

6.  Structure and function of the murine chemokine receptor CXCR3.

Authors:  B Lu; A Humbles; D Bota; C Gerard; B Moser; D Soler; A D Luster; N P Gerard
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

7.  Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice.

Authors:  Y Zhang; S F Schlossman; R A Edwards; Ching-Nan Ou; J Gu; Mei X Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

Review 8.  Chemokine receptor CXCR3: an unexpected enigma.

Authors:  Liping Liu; Melissa K Callahan; DeRen Huang; Richard M Ransohoff
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

9.  Donor-derived IP-10 initiates development of acute allograft rejection.

Authors:  W W Hancock; W Gao; V Csizmadia; K L Faia; N Shemmeri; A D Luster
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

10.  Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Authors:  W W Hancock; B Lu; W Gao; V Csizmadia; K Faia; J A King; S T Smiley; M Ling; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  30 in total

1.  The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2.

Authors:  Xiaoqin Lan; Fang Xiao; Qiang Ding; Jiqiao Liu; Jingmei Liu; Junhua Li; Jiong Zhang; De-An Tian
Journal:  J Mol Histol       Date:  2014-08-24       Impact factor: 2.611

Review 2.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

3.  Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation.

Authors:  Jeffrey S Smith; Lowell T Nicholson; Jutamas Suwanpradid; Rachel A Glenn; Nicole M Knape; Priya Alagesan; Jaimee N Gundry; Thomas S Wehrman; Amber Reck Atwater; Michael D Gunn; Amanda S MacLeod; Sudarshan Rajagopal
Journal:  Sci Signal       Date:  2018-11-06       Impact factor: 8.192

4.  Requirement of Galphai in thymic homing and early T cell development.

Authors:  YongZhu Jin; Mei X Wu
Journal:  Mol Immunol       Date:  2008-05-23       Impact factor: 4.407

5.  Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Authors:  D J Scholten; M Canals; M Wijtmans; S de Munnik; P Nguyen; D Verzijl; I J P de Esch; H F Vischer; M J Smit; R Leurs
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 6.  Pancreatic islet inflammation: an emerging role for chemokines.

Authors:  J Jason Collier; Tim E Sparer; Michael D Karlstad; Susan J Burke
Journal:  J Mol Endocrinol       Date:  2017-04-18       Impact factor: 5.098

7.  Conventional Treatment of Glioblastoma Reveals Persistent CD44+ Subpopulations.

Authors:  Johann Mar Gudbergsson; Esben Christensen; Serhii Kostrikov; Torben Moos; Meg Duroux; Andreas Kjær; Kasper Bendix Johnsen; Thomas Lars Andresen
Journal:  Mol Neurobiol       Date:  2020-07-06       Impact factor: 5.590

Review 8.  Implications of non-canonical G-protein signaling for the immune system.

Authors:  Cédric Boularan; John H Kehrl
Journal:  Cell Signal       Date:  2014-02-28       Impact factor: 4.315

9.  Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs.

Authors:  I Y Hwang; C Park; K A Harrision; N N Huang; J H Kehrl
Journal:  Genes Immun       Date:  2010-05-27       Impact factor: 2.676

10.  Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils.

Authors:  Yoshihiro Kuwano; Micha Adler; Hong Zhang; Alex Groisman; Klaus Ley
Journal:  J Immunol       Date:  2016-03-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.